R&D News | pharmaphorum

News

Novo Nordisk’s head of development Martin Holst Lange

Novo Nordisk agrees $1.1bn takeover of RNA biotech Cardior

Novo Nordisk has reached an agreement to buy Germany’s Cardior Pharmaceuticals for €1.025 billion ($1.1 billion), adding expertise in RNA therapeutics and a heart failure

News

Mirador’s massive $400m first round, and other financings

If any more evidence were needed of a bounceback in venture financing for biotechs after a dip in 2023, the $400 million first round just announced by Mirador Therapeutics

News

xenotransplantation of pig kidney to human

Scientists hail first pig-to-man kidney transplant

Surgeons in the US have carried out the world’s first transplant of a pig kidney into a human, a feat made possible by genetic modification of the organ and an experimenta

News

MS research network taps Seqster for data sharing

A research initiative in multiple sclerosis launched with support from Novartis has partnered with Seqster to provide a unified platform for data sharing, supporting patie

News

Clasp Therapeutics chief executive Rob Ross

Clasp emerges with $150m for safer T-cell engagers

Clasp Therapeutics has burst onto the T-cell engager (TCE) scene with $150 million in funding for a platform that aims to improve the safety of the class, which is current

News

Gates, Wellcome-backed TB vaccine starts phase 3 trial

A huge and much-anticipated phase 3 trial of a new tuberculosis vaccine has kicked off in South Africa, raising hopes of a better way to tackle a disease that – despite be

Novo Nordisk agrees $1.1bn takeover of RNA biotech Cardior

Mirador’s massive $400m first round, and other financings

Scientists hail first pig-to-man kidney transplant

MS research network taps Seqster for data sharing

Clasp emerges with $150m for safer T-cell engagers

Gates, Wellcome-backed TB vaccine starts phase 3 trial

UK seeks views on indefinite CE marks for medical devices

How to meet your physicians where they are online

News

Editor's Picks